Next Article in Journal
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein
Next Article in Special Issue
Acquired Thrombotic Thrombocytopenic Purpura Following Inactivated COVID-19 Vaccines: Two Case Reports and a Short Literature Review
Previous Article in Journal
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination
Previous Article in Special Issue
Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2
 
 
Case Report

Article Versions Notes

Vaccines 2022, 10(4), 532; https://doi.org/10.3390/vaccines10040532
Action Date Notes Link
article xml file uploaded 29 March 2022 12:58 CEST Original file -
article xml uploaded. 29 March 2022 12:58 CEST Update https://www.mdpi.com/2076-393X/10/4/532/xml
article pdf uploaded. 29 March 2022 12:58 CEST Version of Record https://www.mdpi.com/2076-393X/10/4/532/pdf
article html file updated 29 March 2022 12:59 CEST Original file https://www.mdpi.com/2076-393X/10/4/532/html
Back to TopTop